Cartilage Tissue Engineering via Characterization and Application of Carboxymethyl Chitosan-Based Bioink
International researchers continue the trend in exploring natural biomaterials for bioprinting, detailing their findings in the recently published ‘Characterization and Application of Carboxymethyl Chitosan-Based Bioink in Cartilage Tissue Engineering.’
Examining chitosan as an ingredient for bioink in cartilage tissue engineering, the authors realize previous challenges in using printable inks overall—along with difficulty in sustaining cells in the lab environment. Such material has been featured in 4D printing studies, along with experimentation in bioprinting with chitosan-gelatin hydrogels.
Chemical crosslinking has also been used by many research teams, employing chemicals like glutaraldehyde, formaldehyde, and carbodiimide; however, many such agents are high in toxicity, leading to negative reactions. Because chitosan is a natural polysaccharide, it is being used more often in bioprinting applications.
For this study, the researchers focused on tissue engineering of cartilage, seeking ways to regenerate cells:
“The characteristics of chitosan are similar to those of hyaluronic acid and glycosaminoglycans which are distributed extensively in native cartilage, and the degraded products of chitosan are involved in chondrification,” stated the researchers. “However, the weak mechanical property of pristine chitosan limited its further utilization in cartilage regeneration, and the poor water solubility hinders the large-scale use.”
To overcome hurdles for the development of materials with chitosan, the authors developed ink with ‘enhanced mechanical properties,’ allowing them to print hydrogel templates for cartilage bioprinting. Relying on carboxymethyl chitosan, hydrogels were suitably complemented.
Bioink was created via both pneumatic and piston-driven methods (Hkable 3D):
“In order to maintain the continuity of printed hydrogel line and prevent clogging at the extruder, the diameter of the needle used for 3D printing in this work was 0.5 mm, the air pressure was controlled by an affiliated precise regulator and set at 110 psi, and the travel speed of the extruder was set to 300 mm/min.”
Four bioink samples were evaluated in the study, compared as CE powder weight was kept the same for all but the amount of added chitosan was varied. Experimentation revealed that greater amounts of CE caused higher storage and loss modulus, as it proved also to be the main factor in strength enhancement.
Overall, the bioink showed stability and mechanical properties required for both fast gelation and precision in bioprinting.
“According to the rheology and mechanical testing results, the bioink viscoelastic properties and mechanical strength are tunable by adjustment of the proportions of the components which provides a platform to expand the application of the bioink in tissue engineering,” concluded the authors.
“Furthermore, cell studies with chondrocytes show that the bioink is biocompatible, and it supports cell proliferation as well as helps cells to retain their chondrogenic phenotype. Our results illustrate that the developed bioink has the potential to be adopted for 3D bioprinting of scaffolds for tissue engineering.”
What do you think of this news? Let us know your thoughts! Join the discussion of this and other 3D printing topics at 3DPrintBoard.com.[Source / Images: ‘Characterization and Application of Carboxymethyl Chitosan-Based Bioink in Cartilage Tissue Engineering’]
You May Also Like
Is Bioprinting a Winner-Takes-All Market?
The current thesis on bioprinting goes a little something like this: bioprinting is a collection of a number of different technologies, all with potential. From inkjet, material extrusion, and stereolithography,...
3DPOD Episode 50: DARPA and More with Ken Church, nScrypt CEO
I’m a huge nScrypt fan and love the firm’s technologies. The way they’ve defined their “line in a tool” approach to additive is really inspiring to me. With nScrypt machines,...
AMS 2021: Deconstructing the Timeline to Bioprinted Organs
Automation, healthcare, metal additive manufacturing (AM), and bioprinting were the four big topics discussed at the 2021 Additive Manufacturing Strategies (AMS) summit. The two-day virtual event gathered experts for panel...
Looking towards a FRESH future in 3D bioprinting
FluidForm’s Adam Feinberg will be speaking at 3DPrint.com’s upcoming AMS online industry summit (Feb 9-10, 2021). Register here. On January 16th, 2021, President Joe Biden introduced his science team for the incoming...
View our broad assortment of in house and third party products.